Sam West, postdoctoral researcher12, Jadine Scragg, postdoctoral researcher12, Paul Aveyard, professor123, Jason L Oke, departmental lecturer1, Lia Willis, research assistant1, Stella J P Haffner, research assistant1, Heather Knight, research assistant1, Danni Wang, research fellow1, Sarah Morrow, clinical doctoral fellow1, Laura Heath, clinical doctoral fellow1, Susan A Jebb, professor124, Dimitrios A Koutoukidis, associate professor12 1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK 2 National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK 3 National Institute for Health Research, Oxford Health Biomedical Centre, Warneford Hospital, Oxford, UK 4 National Institute for Health Research Applied Research Collaboration, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Correspondence to: S West sam phc.ox.ac.uk (or @_WestSam on X) Accepted 6 November 2025 Abstract Objectives To quantify and compare the rate of weight regain after cessation of weight management medications (WMMs) in adults with overweight or obesity
The results were compared with those generated by Sentosa SQ HCV Genotyping Assay and another widely used commercial assay based on reverse hybridization, the line probe assay (VERSANT HCV Genotype 2.0 Line Probe Assay, Siemens Healthcare Molecular Diagnostics, Berkeley, California)
Our analysis supports the notion that caspase-8 and ROS may act as the platforms regulating the interplay between eryptosis and erythronecroptosis
The compound exists, for practical purposes, as a subject of academic interest in animal studies and as a product available from gray-market vendors and nowhere else in the supply chain
The timely diagnosis and correct management are of utmost importance as they can prevent complications and support the overall health of the individual
/assets/images/provider/photos/2716633.jpg)
